Structural mechanism of SAM-AMP and SAM-AMP2 synthesis by the type III-D2 CRISPR effector complex

The type III-D2 CRISPR-Cas system comprises multiple Cas subunits and a CRISPR RNA, and is likely an evolutionary intermediate between the well-studied type III-A and III-E systems. Here we show that the type III-D2 complex synthesizes two distinct second messengers, SAM-AMP and SAM-AMP2, from S-adenosylmethionine (SAM) and ATP in response to target RNA recognition. We determined cryo-electron microscopy structures of the type III-D2 effector complex in different functional states, providing mechanistic insights into target RNA cleavage and second messenger synthesis. The structures reveal how SAM and ATP are recognized by the Cas10 subunit within the effector complex. Furthermore, our biological data suggest that both SAM-AMP and SAM-AMP2 act on the CorA ancillary effector, inducing growth arrest of infected bacterial cells and thereby conferring immunity. Thus, our study establishes the type III-D2 system as a unique anti-phage defense mechanism that employs both SAM-AMP and SAM-AMP2 as second messengers, expanding the repertoire of second messenger strategies in bacterial defense systems and highlighting the remarkable functional diversity of CRISPR-Cas systems. CRISPR-Cas systems protect bacteria against viruses and other foreign nucleic acids, sometimes involving second messengers that induce antiviral responses. Here, Mitsuda et al. show that the type III-D2 CRISPR-Cas system recognizes a target RNA and synthesizes two distinct second messengers that trigger growth arrest of bacterial cells, thus conferring immunity.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2026-06-24
DOI
https://doi.org/10.1038/s41467-026-74422-0
Primary Topic
CRISPR and Genetic Engineering
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Structural mechanism of SAM-AMP and SAM-AMP2 synthesis by the type III-D2 CRISPR effector complex

Kazuki Kato, Maki Sugaya, Tsuyoshi Osawa, Omar O. Abudayyeh et al.
Nature Communications
CRISPR and Genetic Engineering
article

Structural mechanism of SAM-AMP and SAM-AMP2 synthesis by the type III-D2 CRISPR effector complex

Kazuki Kato, Maki Sugaya, Tsuyoshi Osawa, Omar O. Abudayyeh, Hiroshi Nishimasu, Junichiro Ishikawa, Masahiro Hiraizumi, Jonathan S. Gootenberg, Keitaro Yamashita, Naoto Nagahata, Sae Okazaki, Yoshihisa Mitsuda
article en

Abstract

The type III-D2 CRISPR-Cas system comprises multiple Cas subunits and a CRISPR RNA, and is likely an evolutionary intermediate between the well-studied type III-A and III-E systems. Here we show that the type III-D2 complex synthesizes two distinct second messengers, SAM-AMP and SAM-AMP2, from S-adenosylmethionine (SAM) and ATP in response to target RNA recognition. We determined cryo-electron microscopy structures of the type III-D2 effector complex in different functional states, providing mechanistic insights into target RNA cleavage and second messenger synthesis. The structures reveal how SAM and ATP are recognized by the Cas10 subunit within the effector complex. Furthermore, our biological data suggest that both SAM-AMP and SAM-AMP2 act on the CorA ancillary effector, inducing growth arrest of infected bacterial cells and thereby conferring immunity. Thus, our study establishes the type III-D2 system as a unique anti-phage defense mechanism that employs both SAM-AMP and SAM-AMP2 as second messengers, expanding the repertoire of second messenger strategies in bacterial defense systems and highlighting the remarkable functional diversity of CRISPR-Cas systems. CRISPR-Cas systems protect bacteria against viruses and other foreign nucleic acids, sometimes involving second messengers that induce antiviral responses. Here, Mitsuda et al. show that the type III-D2 CRISPR-Cas system recognizes a target RNA and synthesizes two distinct second messengers that trigger growth arrest of bacterial cells, thus conferring immunity.

Nature CommunicationsVol. 17(1)
Brigham and Women's Hospital (US), Beth Israel Deaconess Medical Center (US), Harvard University (US), Inamori Foundation (JP), Cell and Gene Therapy Catapult (GB), Japan Research Institute (JP), The University of Tokyo (JP)
Japan Agency for Medical Research and Development, University of Tokyo, National Institutes of Health, McGovern Institute for Brain Research, Massachusetts Institute of Technology, Japan Society for the Promotion of Science, National Human Genome Research Institute, Core Research for Evolutional Science and Technology, ACT-X
Openalex Percentile: Top 11%
CRISPR and Genetic Engineering
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.